MaxCyte (MXCT) Stock Chart & Stock Price History $3.58 -0.05 (-1.38%) (As of 03:40 PM ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends MaxCyte Stock Price Performance 5 Day Performance+1.70%1 Month Performance-5.04%3 Month Performance-12.47%6 Month Performance-19.37%Year-To-Date Performance-23.83%1 Year Performance-28.11% Receive MXCT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for MaxCyte and its competitors with MarketBeat's FREE daily newsletter. Email Address BofA is watching for a market top (Ad)U.S. tech stocks have soared so high for so long that they're no longer just minting new millionaires... They're minting new billionaires. The number of American billionaires has skyrocketed over last year – their wealth hitting a record $12.1 trillion – thanks to the Nasdaq's extraordinary outperformance. But now, after two years of near-vertical gains...New warnings out of Wall Street suggest that the winds are about to change. MXCT Stock Chart for Tuesday, December, 3, 2024 MXCT Chart by TradingView MaxCyte Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization12/02/2024$3.55$3.63+2.25%$3.70$3.53656,601 shs$382.90 million11/29/2024$3.52$3.55+0.85%$3.62$3.46355,242 shs$374.47 million11/28/2024$3.52$3.52$3.58$3.38776,537 shs$371.29 million11/27/2024$3.38$3.52+4.14%$3.58$3.38776,537 shs$371.29 million11/26/2024$3.61$3.38-6.37%$3.61$3.33966,975 shs$356.52 million11/25/2024$3.55$3.61+1.69%$3.75$3.522.92 million shs$380.78 million Get the Latest News and Ratings for MXCT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for MaxCyte and its competitors with MarketBeat's FREE daily newsletter. 11/22/2024$3.47$3.55+2.45%$3.63$3.39516,968 shs$374.45 million11/21/2024$3.49$3.47-0.72%$3.51$3.36554,276 shs$365.49 million11/20/2024$3.33$3.49+4.80%$3.50$3.30447,641 shs$368.14 million11/19/2024$3.23$3.33+3.10%$3.36$3.17579,077 shs$351.25 million11/18/2024$3.42$3.23-5.56%$3.45$3.22675,341 shs$340.70 million11/15/2024$3.44$3.42-0.58%$3.53$3.36890,394 shs$360.74 million11/14/2024$3.55$3.44-3.10%$3.61$3.41969,010 shs$362.85 million11/13/2024$3.54$3.55+0.28%$3.60$3.40662,905 shs$374.45 million11/12/2024$3.58$3.54-1.12%$3.64$3.43796,659 shs$373.41 million11/11/2024$3.39$3.58+5.76%$3.60$3.23654,041 shs$377.63 million11/08/2024$3.46$3.38-2.31%$3.63$3.37480,987 shs$356.37 million11/07/2024$3.88$3.46-10.82%$4.01$3.342.36 million shs$364.79 million11/06/2024$3.86$3.88+0.52%$4.15$3.80870,131 shs$409.07 million11/05/2024$3.76$3.86+2.66%$3.87$3.70314,138 shs$405.96 million11/04/2024$3.77$3.76-0.27%$3.82$3.65319,614 shs$395.44 million Related Companies Evolent Health Stock Price Chart NV5 Global Stock Price Chart Custom Truck One Source Stock Price Chart LegalZoom.com Stock Price Chart TaskUs Stock Price Chart Fiverr International Stock Price Chart Phreesia Stock Price Chart Paysafe Stock Price Chart Global Blue Group Stock Price Chart Advantage Solutions Stock Price Chart Receive MXCT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for MaxCyte and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:MXCT) was last updated on 12/3/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredIs NVDA a sell? Buy this stock instead before Dec 3After months of speculation that Nvidia was "cooling off..." and "running out of steam..." The company is m...Chaikin Analytics | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MaxCyte, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MaxCyte With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.